Table 1.
Patient details and clinicopathological features
| Esophageal cancer | Gastric cancer | Hepatocellular carcinoma | |
|---|---|---|---|
| Number | 85 | 248 | 44 |
| Gender | |||
| Male | 73 (85.9) | 181 (73.0%) | 37 (84.1) |
| Female | 12 (14.1) | 67 (23.0) | 7 (15.9) |
| Mean age ± s.d. (y) | 68.2 ± 7.7 | 67.1 ± 10.5 | 63.4 ± 10.3 |
| Age range (y) | 45‐85 | 36‐89 | 46‐85 |
| T‐classification | |||
| T1 | 28 (32.9) | 137 (55.2) | 8 (18.2) |
| T2 | 8 (9.4) | 32 (12.9) | 15 (34.1) |
| T3 | 29 (34.1) | 31 (12.5) | 14 (31.8) |
| T4 | 20 (23.5) | 48 (19.4) | 7 (15.9) |
| Lymph node metastasis | |||
| Positive | 56 (65.9) | 104 (41.9) | 2 (4.5) |
| Negative | 29 (34.1) | 146 (58.1) | 42 (95.5) |
| Distant metastasis | |||
| Positive | 19 (22.4) | 47 (19.0) | 5 (11.4) |
| Negative | 66 (77.6) | 201 (81.0) | 39 (88.6) |
| TNM stage | |||
| I | 26 (30.6) | 155 (62.5) | 8 (18.2) |
| II | 7 (8.2) | 8 (3.2) | 13 (29.5) |
| III | 19 (22.4) | 28 (11.3) | 13 (29.5) |
| IV | 33 (38.8) | 57 (23.0) | 10 (22.8) |
Abbreviations: s.d., standard deviation.